Tarng D C, Cho Y L, Liu H N, Huang T P
Department of Medicine, Veterans General Hospital-Taipei, Taiwan.
Nephron. 1996;72(4):617-22. doi: 10.1159/000188949.
Pruritus is a significant symptom among patients receiving hemodialysis. However, its underlying mechanisms remain obscure. Substance P, a neuropeptide, has been implicated in the mediation of pain and some itch sensations. Local application of capsaicin depletes the peripheral neurons of substance P and may block the conduction of pain or pruritus. This study aims to assess the efficacy and safety of capsaicin 0.025% cream in the treatment of hemodialysis-related pruritus and to further explore the underlying pathomechanism. Nineteen hemodialysis patients with idiopathic, moderate (n = 5) to severe (n = 14) pruritus were examined in a double-blind, placebo-controlled, crossover study and 17 of them completed the study. Topical agent of capsaicin or placebo base cream was applied to localized areas of pruritus 4 times a day. The severity of pruritus and treatment-related side effects (cutaneous burning/stinging sensations, dryness, or erythema) were evaluated weekly. The results showed (1) that 14 of 17 patients reported marked relief and 5 of these 14 patients had complete remission of pruritus during capsaicin treatment (Wilcoxon signed-ranks test, 2p < 0.001); (2) capsaicin was significantly more effective than placebo (Mann-Whitney rank sum test, 2p < 0.001) and a prolonged antipruritic effect was observed 8 weeks posttreatment; (3) no serious side effects were noted during the study and (4) there were no significant changes in serum concentrations of albumin, calcium, phosphorus, alkaline phosphatase, or intact parathyroid hormone during the treatment with either capsaicin or placebo. In summary, the present study indicates indirectly that idiopathic pruritus in some patients on maintenance hemodialysis may be transmitted by substance P from the peripheral sensory neurons to the central nervous system. Topical capsaicin with the unique pharmacological effect is demonstrated to markedly improve the pruritus of these patients.
瘙痒是接受血液透析的患者的一个重要症状。然而,其潜在机制仍不清楚。P物质是一种神经肽,与疼痛和一些瘙痒感觉的介导有关。局部应用辣椒素可耗尽P物质的外周神经元,并可能阻断疼痛或瘙痒的传导。本研究旨在评估0.025%辣椒素乳膏治疗血液透析相关瘙痒的疗效和安全性,并进一步探讨其潜在的发病机制。在一项双盲、安慰剂对照、交叉研究中,对19例患有特发性、中度(n = 5)至重度(n = 14)瘙痒的血液透析患者进行了检查,其中17例完成了研究。将辣椒素或安慰剂基础乳膏局部应用于瘙痒部位,每天4次。每周评估瘙痒的严重程度和与治疗相关的副作用(皮肤烧灼感/刺痛感、干燥或红斑)。结果显示:(1)17例患者中有14例报告瘙痒明显缓解,这14例患者中有5例在辣椒素治疗期间瘙痒完全缓解(Wilcoxon符号秩检验,P < 0.001);(2)辣椒素比安慰剂显著更有效(Mann-Whitney秩和检验,P < 0.001),并且在治疗后8周观察到了延长的止痒效果;(3)研究期间未观察到严重副作用;(4)在用辣椒素或安慰剂治疗期间,血清白蛋白、钙、磷、碱性磷酸酶或完整甲状旁腺激素的浓度没有显著变化。总之,本研究间接表明,一些维持性血液透析患者的特发性瘙痒可能通过P物质从外周感觉神经元传递到中枢神经系统。具有独特药理作用的局部应用辣椒素被证明可显著改善这些患者的瘙痒症状。